David joined Karyopharm in April 2021 and is responsible for Global Medical Scientific Affairs and Customer Excellence and Operations.
David has built a 20+ year career driving growth at a number of leading pharmaceutical companies in both US and international markets and across multiple therapeutic categories, including psychiatry, neurology, and respiratory health. His strategic leadership has helped create motivated and aspirational corporate cultures while also delivering strong financial results at companies including Sunovion, Forest Laboratories, and Pfizer. David has directed commercial operations in complex, matrix-based global organizations and has supported clinical teams by providing commercial guidance throughout the drug development process. David has deep experience in M&A, licensing, and managing global partnerships and has served in leadership roles across the US, Canada, EMEA, and Europe.
David received his Master of Business Administration degree from the University of Bradford in Bradford, West Yorkshire, UK, and his Bachelor of Science in Biochemistry from University of Southampton in Southampton, UK.